Cite
Efficacy of D5F3 IHC for detecting ALK gene rearrangement in NSCLC patients: a systematic review and meta-analysis.
MLA
Ma, Hu, et al. “Efficacy of D5F3 IHC for Detecting ALK Gene Rearrangement in NSCLC Patients: A Systematic Review and Meta-Analysis.” Oncotarget, vol. 7, no. 43, Oct. 2016, pp. 70128–42. EBSCOhost, https://doi.org/10.18632/oncotarget.11806.
APA
Ma, H., Yao, W.-X., Huang, L., Jin, S.-H., Liu, D.-H., Liu, Y., Tian, X., Tian, J.-H., & Zhou, J.-G. (2016). Efficacy of D5F3 IHC for detecting ALK gene rearrangement in NSCLC patients: a systematic review and meta-analysis. Oncotarget, 7(43), 70128–70142. https://doi.org/10.18632/oncotarget.11806
Chicago
Ma, Hu, Wen-Xiu Yao, Lang Huang, Su-Han Jin, Da-Hai Liu, Yuan Liu, Xu Tian, Jin-Hui Tian, and Jian-Guo Zhou. 2016. “Efficacy of D5F3 IHC for Detecting ALK Gene Rearrangement in NSCLC Patients: A Systematic Review and Meta-Analysis.” Oncotarget 7 (43): 70128–42. doi:10.18632/oncotarget.11806.